Johnson & Johnson stock Analysis closes at $263.73, up 0.88%

Johnson & Johnson stock shows a cautiously bullish daily setup, but momentum does not fully endorse it. The completed session price sits above all three daily exponential averages. However, daily MACD remains below its signal, and the hourly chart presents a separate resistance hurdle. Tuesday’s earnings reports add context.

JNJ daily chart with EMA20, EMA50 and volumeJNJ — daily chart with candlesticks, EMA20/EMA50 and volume.

Key takeaways

  • Johnson & Johnson stock closed Monday’s session at $263.73, a 0.88% gain from the previous close of $261.44.

  • The close sits above the daily 20-session EMA at $262.97 and 50-session EMA at $262.74, but below the daily Bollinger mid-band at $264.56.

  • Daily RSI14 is 50.14, above the neutral 50; the daily MACD line at -2.21 is below its signal at -1.7.

  • Next-session daily levels stand at a pivot of $262.83, first resistance at $265.29, and first support at $261.27.

  • In a report published Tuesday after Monday’s session, CNBC said pharmaceutical sales rose 7.7% to $16.76 billion; a Yahoo Finance snapshot reported third-quarter profit of $210 million, or 9 cents per share.

On Monday, October 12, 2026, JNJ opened at $261.6, traded between a low of $260.37 and a high of $264.39, and closed at $263.73. JNJ opened at $261.60, traded between a low of $260.37 and a high of $264.39, and closed at $263.73, against a previous close of $261.44. The gain was 0.88% vs the previous close of $261.44 on October 9, 2026. Prices and technical indicators cited here are from Twelve Data.

Johnson & Johnson stock: daily structure leads, momentum qualifies

Johnson & Johnson stock holds a bullish daily structure: the session close sits above the 20-session, 50-session, and 200-session EMAs. The 20-session EMA stands at $262.97, above the 50-session EMA at $262.74 and the 200-session EMA at $241.55. That ordering supports the main bullish bias. However, the close remains below the daily Bollinger mid-band at $264.56. The upper band is $276.72 and the lower band is $252.4, placing the close in the lower half of that envelope.

Meanwhile, daily RSI14 rose to 50.14 from 46.71 in the preceding session, putting it just above neutral. The daily MACD histogram increased to -0.51 from -1.06, but remains negative. Its line at -2.21 is below the signal at -1.7, leaving a clear qualification to the bullish average structure. Daily ATR14 reads $5.17, providing a volatility reference rather than a directional signal.

For the next session, the daily pivot sits at $262.83, with first resistance at $265.29 and first support at $261.27. These are reference levels for trading when it resumes, not levels attributed to Monday’s intraday path.

Hourly confirmation is incomplete

Hourly confirmation is incomplete: the session close sits above the 20-hour and 50-hour EMAs, but below the 200-hour EMA. The 20-hour EMA stands at $260.79 and the 50-hour EMA at $259.99. However, the close remains below the 200-hour EMA at $264.26, so the hourly averages are not fully bullishly aligned.

Hourly averages and momentum

Meanwhile, hourly RSI14 increased to 69.08 from 65.9, placing it below the overbought threshold. The MACD line at 1.69 exceeds its signal at 1.31, with a positive histogram of 0.39. That supports the daily bullish bias, but does not remove the overhead average.

In addition, the session close sits above the hourly Bollinger mid-band at $259.73 and below its upper band at $266.61. Hourly ATR14 is $1.49. When trading resumes, the hourly pivot is $263.71, with first resistance at $264.69 and first support at $263.03. The session close is just above that next-session pivot.

15-minute execution context

For execution context only, the 15-minute averages are bullishly aligned beneath the session close. The 20-, 50- and 200-period EMAs stand at $262.95, $261.52 and $260.75. Nevertheless, the 15-minute MACD line at 0.57 is below its signal at 0.65, with a negative histogram of -0.08. RSI14 is 68.01, below overbought. The close sits above the Bollinger mid-band at $263.12 but below the upper band at $263.75. ATR14 is $0.6. The 15-minute pivot for the next session is $263.83, with first resistance at $264.57 and first support at $263.28.

Earnings coverage belongs to the following morning

Earnings coverage belongs to Tuesday morning, not to Monday’s completed session. CNBC’s report published on Tuesday, October 13, 2026, after Monday’s session, said pharmaceutical sales rose 7.7% to $16.76 billion. CNBC reported medical technology sales increased 2.5% to $8.6 billion.

A Yahoo Finance earnings snapshot published that morning reported third-quarter profit of $210 million, or 9 cents per share. In contrast, during Monday’s session, Seeking Alpha’s earnings preview described expectations for lower earnings per share and higher revenue. The subsequent reports provide earnings context, but the supplied figures do not establish whether results exceeded those expectations.

Johnson & Johnson stock: bullish and bearish conditions for the next session

For Johnson & Johnson stock, holding the daily 20-session and 50-session EMAs is the core bullish condition. A break below those levels would instead open the bearish case.

Bullish case for JNJ

Clearing the hourly 200-hour EMA at $264.26, then the daily Bollinger mid-band at $264.56, would strengthen the bullish case. Above those levels, the next-session daily first resistance at $265.29 becomes the relevant reference. A daily MACD line above its signal would also remove the current momentum conflict.

Bearish scenario

Conversely, a break below the daily EMAs at $262.97 and $262.74 would undermine the bullish structure around the session close. A subsequent break below next-session daily first support at $261.27 would invalidate the near-term bullish case. The daily lower Bollinger band at $252.4 provides a farther downside reference, not a predicted destination.

Overall, JNJ stands above its daily averages but below the hourly 200-hour EMA and daily Bollinger mid-band. Daily ATR14 of $5.17 frames volatility, while mixed MACD readings keep confirmation incomplete. The unresolved question is whether trading after the earnings reports can sustain the daily support structure and clear those overhead levels.

FAQ

Where did Johnson & Johnson stock close on Monday, October 12, 2026?

Johnson & Johnson stock closed at $263.73, up 0.88% from the previous close of $261.44 on October 9, 2026.

What do the daily technicals show for JNJ?

The close sits above the daily 20-session EMA at $262.97 and 50-session EMA at $262.74. However, it remains below the daily Bollinger mid-band at $264.56, and the daily MACD line at -2.21 is below its signal at -1.7.

What are the next-session levels for Johnson & Johnson stock?

The daily pivot is $262.83, with first resistance at $265.29 and first support at $261.27. On the hourly chart, the pivot is $263.71, with first resistance at $264.69 and first support at $263.03.

What earnings reports were published after Monday’s session?

In a report published Tuesday after Monday’s session, CNBC said pharmaceutical sales rose 7.7% to $16.76 billion and medical technology sales increased 2.5% to $8.6 billion. A Yahoo Finance snapshot published Tuesday after Monday’s session reported third-quarter profit of $210 million, or 9 cents per share.

Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.

Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.